Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of early postnatal supplementation of newborns with probiotic strain E. coli O83:K24:H31 on allergy incidence, dendritic cells, and microbiota. | Front Immunol | 2022 | 36703968 | PubTator, text mining | PubMed |
| Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer. | Front Oncol | 2022 | 36703796 | PubTator, text mining | PubMed |
| E, K, B5, B6, and B9 vitamins and their specific immunological effects evaluated by flow cytometry. | Front Med (Lausanne) | 2022 | 36687400 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis. | Front Oncol | 2022 | 36686830 | PubTator, text mining | PubMed |
| Editorial: Targeting TNF/TNFR signaling pathways. | Front Pharmacol | 2022 | 36686715 | PubTator, text mining | PubMed |
| Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma. | Front Genet | 2022 | 36685979 | PubTator, text mining | PubMed |
| Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer. | Front Genet | 2022 | 36685937 | PubTator, text mining | PubMed |
| Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis. | Front Immunol | 2022 | 36685593 | PubTator, text mining | PubMed |
| Spatial genomics reveals a high number and specific location of B cells in the pancreatic ductal adenocarcinoma microenvironment of long-term survivors. | Front Immunol | 2022 | 36685537 | PubTator, text mining | PubMed |
| Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection. | Front Immunol | 2022 | 36685527 | PubTator, text mining | PubMed |
| Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma. | J Pers Med | 2022 | 36675674 | PubTator, text mining | PubMed |
| Circulating Regulatory B-Lymphocytes in Patients with Acute Myocardial Infarction: A Pilot Study. | J Cardiovasc Dev Dis | 2022 | 36661897 | PubTator, text mining | PubMed |
| Bioinformatics analysis identifies PSMB8 as a key gene in the cutaneous malignant melanoma tumor microenvironment. | Ann Transl Med | 2022 | 36660621 | PubTator, text mining | PubMed |
| The Role of Immune Checkpoint Inhibitors in Cancer Therapy. | Clin Pract | 2022 | 36648843 | PubTator, text mining | PubMed |
| High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma. | J Thorac Dis | 2022 | 36647484 | PubTator, text mining | PubMed |
| Immune checkpoint blockade for locally advanced or recurrent/metastatic cervical cancer: An update on clinical data. | Front Oncol | 2022 | 36644634 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review. | JACC CardioOncol | 2022 | 36636451 | PubTator, text mining | PubMed |
| A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma. | Transl Androl Urol | 2022 | 36632155 | PubTator, text mining | PubMed |
| Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma. | Dis Markers | 2022 | 36618968 | PubTator, text mining | PubMed |
| Inflammatory checkpoints in amyotrophic lateral sclerosis: From biomarkers to therapeutic targets. | Front Immunol | 2022 | 36618399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=39